(Q44170367)

30 November 2017

title

Occurrence of vaccine and non-vaccine human papillomavirus types in adolescent Finnish females 4 years post-vaccination (English)

1 reference

30 November 2017

0 references

1 reference

Dan Apter

4

0 references

Jorma Paavonen

3

object named as

Jorma Paavonen

1 reference

30 November 2017

Johanna Palmroth

1

1 reference

30 November 2017

Marko Merikukka

2

1 reference

30 November 2017

Tiina Eriksson

5

1 reference

30 November 2017

Kari Natunen

6

1 reference

30 November 2017

Gary Dubin

7

1 reference

30 November 2017

Matti Lehtinen

8

1 reference

30 November 2017

language of work or name

English

0 references

publication date

30 April 2012

1 reference

International Journal of Cancer

30 November 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

30 November 2017

volume

131

1 reference

30 November 2017

issue

12

1 reference

30 November 2017

page(s)

2832-2838

1 reference

Vaccination against colonizing bacteria with multiple serotypes

30 November 2017

cites work

1 reference

Serotype replacement in disease after pneumococcal vaccination

21 January 2018

1 reference

Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study

21 January 2018

1 reference

The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia.

21 January 2018

1 reference

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years

21 January 2018

1 reference

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

21 January 2018

1 reference

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

21 January 2018

1 reference

Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.

21 January 2018

1 reference

Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33.

21 January 2018

1 reference

Coinfection and the evolution of parasite virulence

21 January 2018

1 reference

Superinfection and the evolution of parasite virulence.

21 January 2018

1 reference

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

21 January 2018

1 reference

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

21 January 2018

1 reference

Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR.

21 January 2018

1 reference

A review of human carcinogens--Part B: biological agents

21 January 2018

1 reference

Seroprevalence atlas of infections with oncogenic and non-oncogenic human papillomaviruses in Finland in the 1980s and 1990s

21 January 2018

1 reference

Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles.

21 January 2018

1 reference

Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica.

21 January 2018

1 reference

The natural history of cervical HPV infection: unresolved issues

21 January 2018

1 reference

Human papillomavirus infections with multiple types and risk of cervical neoplasia.

21 January 2018

1 reference

No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11.

21 January 2018

1 reference

Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer

21 January 2018

1 reference

Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women

21 January 2018

1 reference

Cervical Coinfection with Human Papillomavirus (HPV) Types as a Predictor of Acquisition and Persistence of HPV Infection

21 January 2018

1 reference

Cervical Coinfection with Human Papillomavirus (HPV) Types and Possible Implications for the Prevention of Cervical Cancer by HPV Vaccines

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.27586

1 reference

30 November 2017

1 reference